The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C
of the blood supply. He was a major contributor in the fight to reduce the incidence of transfusion-induced viral hepatitis, and he collaborated in the discovery of hepatitis C and described its natural history. He is a member of IOM and NAS. For his contributions, Dr. Alter has been awarded the US Pubic Health Service Distinguished Service Medal, the Landsteiner Prize, the Presidential Award of the International Society of Blood Transfusion, the James Blundell Award of the British Blood Transfusion Society, and the Distinguished Scientist Awards of both the Hepatitis B Foundation and the American Liver Foundation, and he was elected to fellowship in the American Association of Physicians. He was the corecipient of the 2000 Clinical Lasker Award and was made a master of the American College of Physicians. In 2007, he was named Distinguished NIH Investigator. Dr. Alter received his MD from the University of Rochester.
Margaret L. Brandeau, PhD, is a professor in the Department of Management Science and Engineering of Stanford University. She also holds a courtesy appointment in the Department of Medicine of the same institution. Dr. Brandeau is an operations researcher and policy analyst with extensive background in the development of applied mathematical and economic models. She has conducted research on HIV, focusing on mathematical and economic models to assess the value of different HIV and drug-abuse interventions, and on hepatitis B screening and vaccination policies. She received her PhD in engineering and economic systems from Stanford University.
Daniel R. Church, MPH, is the adult viral hepatitis prevention coordinator and an epidemiologist in the Division of Epidemiology and Immunization of the Massachusetts Department of Health. He coordinates the statewide viral hepatitis program, including disease surveillance; medical-management services; counseling and testing programs; adult vaccination programs; educational campaigns for providers, patients, and communities; and evaluation of projects. Mr. Church received his MPH in epidemiology and biostatistics from the Boston University School of Public Health.
Alison A. Evans, ScD, is an assistant professor in the Department of Epidemiology and Biostatistics of the Drexel University School of Public Health. She is also the director of public-health research in the Hepatitis B Foundation, Doylestown, PA, and is an adjunct associate member of the Fox Chase Cancer Center in Philadelphia, PA. Her research interests include the epidemiology and natural history of the hepatitis B virus and other chronic viral infections. She received her ScD in epidemiology from the Harvard School of Public Health.